Office of Research & Development |
![]() ![]() |
Project Number: | IK1CX002092-01A1 |
Title: | Quantifying oxytocin effects on vocal expression in schizophrenia |
Principal Investigator: | Ellen Bradley |
Location: | San Francisco, CA |
Congressional District Code: | 12 |
Research Service: | Clinical Science R&D |
Project Period: | July 2020 - June 2022 |
FY 2021 Funding Amount: | $240,584 |
Total Award Amount (all years): |
$483,606 |
Abstract: |
View full abstract and other project information on NIH RePORTER Go To NIH RePORTER Excerpt: Schizophrenia is a devastating illness associated with lifelong disability and high health care costs that disproportionately impacts veterans. Negative symptoms, a set of volitional and expressive deficits, are major contributors to impaired functioning. These deficits are poorly understood and difficult to monitor, in part due to a lack of effective measurement tools. Negative symptoms are typically measured using interview-based clinical rating scales, which are imprecise, costly to administe... |